Thursday, February 04, 2016 11:28:50 AM
"Organization and Business
Discovery Minerals Ltd., (OTC PINKSHEETS: DSCR.PK) is an acquisition and development company
that targets natural resource properties through its wholly owned subsidiaries. These projects have
previously fallen within two categories of natural products, precious metals mining and industrial hemp
cultivation and processing. However, Discovery’s future interests and activities will be focused on the
marketing and distribution of Migranade, a naturopathic therapy for migraine headache sufferers, and the
development of several other homeopathic treatments for common human ailments in conjunction with
Doctor Charles Hensley. Dr. Hensley is best known for his groundbreaking treatment for the common
cold, Zicam, released to the market in the late 1990s. Discovery has an agreement in place to secure all
the technology underlying Migranade and the other treatments developed by Dr Hensley.
In addition, the Company is pursuing clean tech and alternative energy investments to be integrated into
these business channels."
DSCR
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM